Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
David Goldgar
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Physiology
Genes & Molecular Sequences
Concepts & Ideas
Chemicals & Drugs
Procedures
Geographic Areas
Sign-in to see full Profile
Network (preview)
22
Skolnick, Mark
19
Cannon-Albright, Lisa
18
Easton, Douglas
16
Tavtigian, Sean
14
Neuhausen, Susan
11
Lenoir, Gilbert
11
Meyer, Laurence
10
Chenevix-Trench, Georgia
10
Sinilnikova, Olga
10
Couch, Fergus J.
9
Simard, Jacques
9
Spurdle, Amanda
9
Chang-Claude, Jenny
9
Antoniou, Antonis
9
Easton, Douglas
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of David Goldgar (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Duffin Kristina Callis; Freeny Ingrid C; Schrodi Steven J; Wong Bob; Feng Bing-Jian; Soltani-Arabshahi Razieh; Rakkhit Tina; Goldgar David E; Krueger Gerald G
Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking.
The Journal of investigative dermatology 2009;129(12):2777-83.
-
2009: Feng B-J; Khyatti M; Ben-Ayoub W; Dahmoul S; Ayad M; Maachi F; Bedadra W; Abdoun M; Mesli S; Bakkali H; Jalbout M; Hamdi-Cherif M; Boualga K; Bouaouina N; Chouchane L; Benider A; Ben-Ayed F; Goldgar D E; Corbex M
Cannabis, tobacco and domestic fumes intake are associated with nasopharyngeal carcinoma in North Africa.
British journal of cancer 2009;101(7):1207-12.
-
2009: Feng Bing-Jian; Sun Liang-Dan; Soltani-Arabshahi Razieh; Bowcock Anne M; Nair Rajan P; Stuart Philip; Elder James T; Schrodi Steven J; Begovich Ann B; Abecasis Gonçalo R; Zhang Xue-Jun; Callis-Duffin Kristina P; Krueger Gerald G; Goldgar David E
Multiple Loci within the major histocompatibility complex confer risk of psoriasis.
PLoS genetics 2009;5(8):e1000606.
-
2009: Arnold Sven; Buchanan Daniel D; Barker Melissa; Jaskowski Lesley; Walsh Michael D; Birney Genevieve; Woods Michael O; Hopper John L; Jenkins Mark A; Brown Melissa A; Tavtigian Sean V; Goldgar David E; Young Joanne P; Spurdle Amanda B
Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics.
Human mutation 2009;30(5):757-70.
-
2009: Spurdle Amanda B; Deans Andrew J; Duffy David; Goldgar David E; Chen Xiaoqing; Beesley Jonathan; Easton Douglas F; Antoniou Antonis C; Peock Susan; Cook Margaret; Nathanson Katherine L; Domchek Susan M; MacArthur Grant A; Chenevix-Trench Georgia
No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2009;115(2):307-13.
-
2009: Johnatty Sharon E; Beesley Jonathan; Chen Xiaoqing; Hopper John L; Southey Melissa C; Giles Graham G; Goldgar David E; Chenevix-Trench Georgia; Spurdle Amanda B;
The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case-control and family analysis.
Breast cancer research and treatment 2009;115(1):145-50.
-
2009: Antoniou Antonis C; Rookus Matti; Andrieu Nadine; Brohet Richard; Chang-Claude Jenny; Peock Susan; Cook Margaret; Evans D Gareth; Eeles Rosalind; Nogues Catherine; Faivre Laurence; Gesta Paul; van Leeuwen Flora E; Ausems Margreet G E M; Osorio Ana; Caldes Trinidad; Simard Jacques; Lubinski Jan; Gerdes Anne-Marie; Olah Edith; Fürhauser Christine; Olsson Hakan; Arver Brita; Radice Paolo; Easton Douglas F; Goldgar David E
Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(2):601-10.
-
2008: Tavtigian Sean V; Byrnes Graham B; Goldgar David E; Thomas Alun
Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications.
Human mutation 2008;29(11):1342-54.
-
2008: Goldgar David E; Easton Douglas F; Byrnes Graham B; Spurdle Amanda B; Iversen Edwin S; Greenblatt Marc S;
Genetic evidence and integration of various data sources for classifying uncertain variants into a single model.
Human mutation 2008;29(11):1265-72.
-
2008: Tavtigian Sean V; Greenblatt Marc S; Goldgar David E; Boffetta Paolo;
Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working Group.
Human mutation 2008;29(11):1261-4.
-
2008: Tischkowitz Marc; Hamel Nancy; Carvalho Marcelo A; Birrane Gabriel; Soni Aditi; van Beers Erik H; Joosse Simon A; Wong Nora; Novak David; Quenneville Louise A; Grist Scott A; Nederlof Petra M; Goldgar David E; Tavtigian Sean V; Monteiro Alvaro N; Ladias John A A; Foulkes William D
Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
European journal of human genetics : EJHG 2008;16(7):820-32.
-
2008: Farrugia Daniel J; Agarwal Mukesh K; Pankratz Vernon S; Deffenbaugh Amie M; Pruss Dmitry; Frye Cynthia; Wadum Linda; Johnson Kiley; Mentlick Jennifer; Tavtigian Sean V; Goldgar David E; Couch Fergus J
Functional assays for classification of BRCA2 variants of uncertain significance.
Cancer research 2008;68(9):3523-31.
-
2008: Spurdle Amanda B; Lakhani Sunil R; Healey Sue; Parry Suzanne; Da Silva Leonard M; Brinkworth Ross; Hopper John L; Brown Melissa A; Babikyan Davit; Chenevix-Trench Georgia; Tavtigian Sean V; Goldgar David E;
Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1657-63.
-
2008: Wong Ee Ming; Tesoriero Andrea A; Pupo Gulietta M; McCredie Margaret R E; Giles Graham G; Hopper John L; Mann Graham J; Goldgar David E; Southey Melissa C
Is MSH2 a breast cancer susceptibility gene?
Familial cancer 2008;7(2):151-5.
-
2007: Easton Douglas F; Deffenbaugh Amie M; Pruss Dmitry; Frye Cynthia; Wenstrup Richard J; Allen-Brady Kristina; Tavtigian Sean V; Monteiro Alvaro N A; Iversen Edwin S; Couch Fergus J; Goldgar David E
A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
American journal of human genetics 2007;81(5):873-83.
-
2007: Feng Bing-Jian; Jalbout Majida; Ayoub Wided Ben; Khyatti Meriem; Dahmoul Sami; Ayad Messaoud; Maachi Fatima; Bedadra Wided; Abdoun Meriem; Mesli Sarah; Hamdi-Cherif Mokhtar; Boualga Kada; Bouaouina Noureddine; Chouchane Lotfi; Benider Abdellatif; Ben Ayed Farhat; Goldgar David; Corbex Marilys
Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries.
International journal of cancer. Journal international du cancer 2007;121(7):1550-5.
-
2007: Brohet Richard M; Goldgar David E; Easton Douglas F; Antoniou Antonis C; Andrieu Nadine; Chang-Claude Jenny; Peock Susan; Eeles Rosalind A; Cook Margaret; Chu Carol; Noguès Catherine; Lasset Christine; Berthet Pascaline; Meijers-Heijboer Hanne; Gerdes Anne-Marie; Olsson Håkan; Caldes Trinidad; van Leeuwen Flora E; Rookus Matti A
Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3831-6.
-
2007: Goldgar David; Venne Vickie; Conner Tom; Buys Saundra
BRCA phenocopies or ascertainment bias?
Journal of medical genetics 2007;44(8):e86; author reply e88.
-
2007: Chang-Claude Jenny; Andrieu Nadine; Rookus Matti; Brohet Richard; Antoniou Antonis C; Peock Susan; Davidson Rosemarie; Izatt Louise; Cole Trevor; Noguès Catherine; Luporsi Elisabeth; Huiart Laetitia; Hoogerbrugge Nicoline; Van Leeuwen Flora E; Osorio Ana; Eyfjord Jorunn; Radice Paolo; Goldgar David E; Easton Douglas F;
Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(4):740-6.
-
2007: Lang Julie; Hayward Nicholas; Goldgar David; Tsao Hensin; Hogg David; Palmer Jane; Stark Mitchell; Tobias Edward S; MacKie Rona
The M53I mutation in CDKN2A is a founder mutation that predominates in melanoma patients with Scottish ancestry.
Genes, chromosomes & cancer 2007;46(3):277-87.
-
2007: Carvalho Marcelo A; Marsillac Sylvia M; Karchin Rachel; Manoukian Siranoush; Grist Scott; Swaby Ramona F; Urmenyi Turan P; Rondinelli Edson; Silva Rosane; Gayol Luis; Baumbach Lisa; Sutphen Rebecca; Pickard-Brzosowicz Jennifer L; Nathanson Katherine L; Sali Andrej; Goldgar David; Couch Fergus J; Radice Paolo; Monteiro Alvaro N A
Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.
Cancer research 2007;67(4):1494-501.
-
2007: Lovelock Paul K; Spurdle Amanda B; Mok Myth T S; Farrugia Daniel J; Lakhani Sunil R; Healey Sue; Arnold Stephen; Buchanan Daniel; Couch Fergus J; Henderson Beric R; Goldgar David E; Tavtigian Sean V; Chenevix-Trench Georgia; Brown Melissa A
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
Breast cancer research : BCR 2007;9(6):R82.
-
2007: Feng Bing-Jian; Goldgar David E; Corbex Marilys
Trend-TDT - a transmission/disequilibrium based association test on functional mini/microsatellites.
BMC genetics 2007;8():75.
-
2007: Gonzalez-Neira Anna; Rosa-Rosa Juan Manuel; Osorio Ana; Gonzalez Emilio; Southey Melissa; Sinilnikova Olga; Lynch Henry; Oldenburg Rogier A; van Asperen Christi J; Hoogerbrugge Nicoline; Pita Guillermo; Devilee Peter; Goldgar David; Benitez Javier
Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies.
BMC genomics 2007;8():299.
-
2007: Chenevix-Trench Georgia; Milne Roger L; Antoniou Antonis C; Couch Fergus J; Easton Douglas F; Goldgar David E;
An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA).
Breast cancer research : BCR 2007;9(2):104.
-
2007: Vogl Florian D; Badzioch Mike D; Steele Linda; Neuhausen Susan L; Goldgar David E
Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred.
Familial cancer 2007;6(1):63-71.
-
2006: Waddell Nic; Jonnalagadda Jyoti; Marsh Anna; Grist Scott; Jenkins Mark; Hobson Karen; Taylor Malcolm; Lindeman Geoff J; Tavtigian Sean V; Suthers Graeme; Goldgar David; Oefner Peter J; Taylor Darrin; Grimmond Sean; Khanna Kum Kum; Chenevix-Trench Georgia
Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling.
Genes, chromosomes & cancer 2006;45(12):1169-81.
-
2006: Andrieu Nadine; Easton Douglas F; Chang-Claude Jenny; Rookus Matti A; Brohet Richard; Cardis Elisabeth; Antoniou Antonis C; Wagner Teresa; Simard Jacques; Evans Gareth; Peock Susan; Fricker Jean-Pierre; Nogues Catherine; Van't Veer Laura; Van Leeuwen Flora E; Goldgar David E
Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3361-6.
-
2006: Andrieu Nadine; Goldgar David E; Easton Douglas F; Rookus Matti; Brohet Richard; Antoniou Antonis C; Peock Susan; Evans Gareth; Eccles Diana; Douglas Fiona; Noguès Catherine; Gauthier-Villars Marion; Chompret Agnès; Van Leeuwen Flora E; Kluijt Irma; Benitez Javier; Arver Brita; Olah Edith; Chang-Claude Jenny;
Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).
Journal of the National Cancer Institute 2006;98(8):535-44.
-
2006: Chenevix-Trench Georgia; Healey Sue; Lakhani Sunil; Waring Paul; Cummings Margaret; Brinkworth Ross; Deffenbaugh Amie M; Burbidge Lynn Anne; Pruss Dmitry; Judkins Thad; Scholl Tom; Bekessy Anna; Marsh Anna; Lovelock Paul; Wong Ming; Tesoriero Andrea; Renard Helene; Southey Melissa; Hopper John L; Yannoukakos Koulis; Brown Melissa; Easton Douglas; Tavtigian Sean V; Goldgar David; Spurdle Amanda B;
Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.
Cancer research 2006;66(4):2019-27.
-
2006: Lovelock P K; Healey S; Au W; Sum E Y M; Tesoriero A; Wong E M; Hinson S; Brinkworth R; Bekessy A; Diez O; Izatt L; Solomon E; Jenkins M; Renard H; Hopper J; Waring P; Tavtigian S V; Goldgar D; Lindeman G J; Visvader J E; Couch F J; Henderson B R; Southey M; Chenevix-Trench G; Spurdle A B; Brown M A;
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.
Journal of medical genetics 2006;43(1):74-83.
-
2006: Saxena Sunita; Chakraborty Anurupa; Kaushal Mishi; Kotwal Sanjeev; Bhatanager Dinesh; Mohil Ravindar S; Chintamani Chintamani; Aggarwal Anil K; Sharma Veena K; Sharma Prakash C; Lenoir Gilbert; Goldgar David E; Szabo Csilla I
Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
BMC medical genetics 2006;7():75.
-
2006: Moisan Anne-Marie; Fortin Jessyka; Dumont Martine; Samson Carolle; Bessette Paul; Chiquette Jocelyne; Laframboise Rachel; Lépine Jean; Lespérance Bernard; Pichette Roxane; Plante Marie; Provencher Louise; Voyer Patricia; Goldgar David; Bridge Peter; Simard Jacques
No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families.
Genetic testing 2006;10(2):104-15.
-
2006: Avard Denise; Bridge Peter; Bucci Lucie M; Chiquette Jocelyne; Dorval Michel; Durocher Francine; Easton Doug; Godard Béatrice; Goldgar David; Knoppers Bartha Maria; Laframboise Rachel; Lespérance Bernard; Plante Marie; Tavtigian Sean V; Vézina Hélène; Wilson Brenda; Simard Jacques
Partnering in oncogenetic research--the INHERIT BRCAs experience: opportunities and challenges.
Familial cancer 2006;5(1):3-13.
-
2005: Hughes David J; Ginolhac Sophie M; Coupier Isabelle; Barjhoux Laure; Gaborieau Valérie; Bressac-de-Paillerets Brigitte; Chompret Agnès; Bignon Yves-Jean; Uhrhammer Nancy; Lasset Christine; Giraud Sophie; Sobol Hagay; Hardouin Agnès; Berthet Pascaline; Peyrat Jean-Philippe; Fournier Joelle; Nogues Catherine; Lidereau Rosette; Muller Danièle; Fricker Jean-Pierre; Longy Michel; Toulas Christine; Guimbaud Rosine; Yannoukakos Drakoulis; Mazoyer Sylvie; Lynch Henry T; Lenoir Gilbert M; Goldgar David E; Stoppa-Lyonnet Dominique; Sinilnikova Olga M
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.
International journal of cancer. Journal international du cancer 2005;117(2):230-3.
-
2005: Vézina Hélène; Durocher Francine; Dumont Martine; Houde Louis; Szabo Csilla; Tranchant Martine; Chiquette Jocelyne; Plante Marie; Laframboise Rachel; Lépine Jean; Nevanlinna Heli; Stoppa-Lyonnet Dominique; Goldgar David; Bridge Peter; Simard Jacques
Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families.
Human genetics 2005;117(2-3):119-32.
-
2005: Antoniou Antonis C; Goldgar David E; Andrieu Nadine; Chang-Claude Jenny; Brohet Richard; Rookus Matti A; Easton Douglas F
A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes.
Genetic epidemiology 2005;29(1):1-11.
-
2005: Thompson Deborah; Antoniou Antonis C; Jenkins Mark; Marsh Anna; Chen Xiaoqing; Wayne Tierney; Tesoriero Andrea; Milne Roger; Spurdle Amanda; Thorstenson Yvonne; Southey Melissa; Giles Graham G; Khanna Kum Kum; Sambrook Joseph; Oefner Peter; Goldgar David; Hopper John L; Easton Doug; Chenevix-Trench Georgia;
Two ATM variants and breast cancer risk.
Human mutation 2005;25(6):594-5.
-
2005: Phelan C M; Dapic V; Tice B; Favis R; Kwan E; Barany F; Manoukian S; Radice P; van der Luijt R B; van Nesselrooij B P M; Chenevix-Trench G; kConFab; Caldes T; de la Hoya M; Lindquist S; Tavtigian S V; Goldgar D; Borg A; Narod S A; Monteiro A N A
Classification of BRCA1 missense variants of unknown clinical significance.
Journal of medical genetics 2005;42(2):138-46.
-
2005: Wu Kangjian; Hinson Shannon R; Ohashi Akihiro; Farrugia Daniel; Wendt Patricia; Tavtigian Sean V; Deffenbaugh Amie; Goldgar David; Couch Fergus J
Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.
Cancer research 2005;65(2):417-26.
-
2005: Chenevix-Trench G; Sinilnikova O M; Suthers G; Pandeya N; Mazoyer S; Sambrook J F; Goldup S; Goldgar D; Lynch H T; Lenoir G M; Cheetham G;
Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers.
Familial cancer 2005;4(2):73-5.
-
2004: Sinilnikova Olga M; Ginolhac Sophie M; Magnard Clémence; Léoné Mélanie; Anczukow Olga; Hughes David; Moreau Karen; Thompson Deborah; Coutanson Christine; Hall Janet; Romestaing Pascale; Gérard Jean-Pierre; Bonadona Valérie; Lasset Christine; Goldgar David E; Joulin Virginie; Venezia Nicole Dalla; Lenoir Gilbert M
Acetyl-CoA carboxylase alpha gene and breast cancer susceptibility.
Carcinogenesis 2004;25(12):2417-24.
-
2004: Thompson Deborah; Witte John S; Slattery Martha; Goldgar David
Increased power for case-control studies of single nucleotide polymorphisms through incorporation of family history and genetic constraints.
Genetic epidemiology 2004;27(3):215-24.
-
2004: Goldgar David E; Easton Douglas F; Deffenbaugh Amie M; Monteiro Alvaro N A; Tavtigian Sean V; Couch Fergus J;
Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.
American journal of human genetics 2004;75(4):535-44.
-
2004: McKay J D; Thompson D; Lesueur F; Stankov K; Pastore A; Watfah C; Strolz S; Riccabona G; Moncayo R; Romeo G; Goldgar D E
Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer.
Journal of medical genetics 2004;41(6):407-12.
-
2004: Szabo Csilla I; Schutte Mieke; Broeks Annegien; Houwing-Duistermaat Jeanine J; Thorstenson Yvonne R; Durocher Francine; Oldenburg Rogier A; Wasielewski Marijke; Odefrey Fabrice; Thompson Deborah; Floore Arno N; Kraan Jaennelle; Klijn Jan G M; van den Ouweland Ans M W; Wagner Teresa M U; Devilee Peter; Simard Jacques; van 't Veer Laura J; Goldgar David E; Meijers-Heijboer Hanne
Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?
Cancer research 2004;64(3):840-3.
-
2004: Satgé Daniel; Sasco Annie J; Goldgar David; Vekemans Michel; Réthoré Marie-Odile
A 23-year-old woman with Down syndrome, type 1 neurofibromatosis, and breast carcinoma.
American journal of medical genetics. Part A 2004;125A(1):94-6.
-
2004: Thiffault I; Hamel N; Pal T; McVety S; Marcus V A; Farber D; Cowie S; Deschênes J; Meschino W; Odefrey F; Goldgar D; Graham T; Narod S; Watters A K; MacNamara E; Du Sart D; Chong G; Foulkes W D
Germline truncating mutations in both MSH2 and BRCA2 in a single kindred.
British journal of cancer 2004;90(2):483-91.
-
2004: Neuhausen Susan; Dunning Alison; Steele Linda; Yakumo Kazuko; Hoffman Michael; Szabo Csilla; Tee Louise; Baines Caroline; Pharoah Paul; Goldgar David; Easton Doug
Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers.
International journal of cancer. Journal international du cancer 2004;108(3):477-8.
-
2003: Slattery M L; Levin T R; Ma K; Goldgar D; Holubkov R; Edwards S
Family history and colorectal cancer: predictors of risk.
Cancer causes & control : CCC 2003;14(9):879-87.
-
2003: Olivier Magali; Goldgar David E; Sodha Nayanta; Ohgaki Hiroko; Kleihues Paul; Hainaut Pierre; Eeles Rosalind A
Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
Cancer research 2003;63(20):6643-50.
-
2003: Thompson Deborah; Easton Douglas F; Goldgar David E
A full-likelihood method for the evaluation of causality of sequence variants from family data.
American journal of human genetics 2003;73(3):652-5.
-
2003: Jakubowska Anna; Narod Steven A; Goldgar David E; Mierzejewski Marek; Masojc Bartlomiej; Nej Katarzyna; Huzarska Jowita; Byrski Tomasz; Górski Bohdan; Lubinski Jan
Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(5):457-9.
-
2003: Campos Berta; Díez Orland; Odefrey Fabrice; Domènech Montserrat; Moncoutier Virginie; Martínez-Ferrandis José Ignacio; Osorio Ana; Balmaña Judith; Barroso Alicia; Armengod María Eugenia; Benítez Javier; Alonso Carmen; Stoppa-Lyonnet Dominique; Goldgar David; Baiget Montserrat
Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain.
Human mutation 2003;21(4):452.
-
2003: Thompson Deborah; Stram Dan; Goldgar David; Witte John S
Haplotype tagging single nucleotide polymorphisms and association studies.
Human heredity 2003;56(1-3):48-55.
-
2003: Sibert Alexandre; Goldgar David E
The effect of disease penetrance, family size, and age of onset on family history with application to setting eligibility criteria for genetic testing.
Familial cancer 2003;2(1):35-42.
-
2002: Ruiz-Flores Pablo; Sinilnikova Olga M; Badzioch Michael; Calderon-Garcidueñas A L; Chopin Sandrine; Fabrice Odefrey; González-Guerrero J F; Szabo Csilla; Lenoir Gilbert; Goldgar David E; Barrera-Saldaña Hugo A
BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico.
Human mutation 2002;20(6):474-5.
-
2002: Zhi Xiangcheng; Szabo Csilla; Chopin Sandrine; Suter Nicola; Wang Qing-Sheng; Ostrander Elaine A; Sinilnikova Olga M; Lenoir Gilbert M; Goldgar David; Shi Yu-Rong
BRCA1 and BRCA2 sequence variants in Chinese breast cancer families.
Human mutation 2002;20(6):474.
-
2002: Saxena Sunita; Szabo Csilla I; Chopin Sandrine; Barjhoux Laure; Sinilnikova Olga; Lenoir Gilbert; Goldgar David E; Bhatanager Dinesh
BRCA1 and BRCA2 in Indian breast cancer patients.
Human mutation 2002;20(6):473-4.
-
2002: Patmasiriwat Pimpicha; Bhothisuwan Kris; Sinilnikova Olga M; Chopin Sandrine; Methakijvaroon Suthida; Badzioch Michael; Padungsutt Puchong; Vattanaviboon Phantip; Vattanasapt Vanchai; Szabo Csilla; Saunders Grady F; Goldgar David; Lenoir Gilbert M
Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
Human mutation 2002;20(3):230.
-
2002: Nathanson Katherine L; Shugart Yin Y; Omaruddin Romaica; Szabo Csilla; Goldgar David; Rebbeck Timothy R; Weber Barbara L
CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q.
Human molecular genetics 2002;11(11):1327-32.
-
2002: Lesueur F; Corbex M; McKay J D; Lima J; Soares P; Griseri P; Burgess J; Ceccherini I; Landolfi S; Papotti M; Amorim A; Goldgar D E; Romeo G
Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma.
Journal of medical genetics 2002;39(4):260-5.
-
2002: Iscovich Jose; Abdulrazik Mohammed; Cour Carol; Fischbein Alf; Pe'er Jacob; Goldgar David E
Prevalence of the BRCA2 6174 del T mutation in Israeli uveal melanoma patients.
International journal of cancer. Journal international du cancer 2002;98(1):42-4.
-
2002: Schneider-Yin Xiaoye; Hergersberg Martin; Goldgar David E; Rüfenacht Urszula B; Schuurmans Macé M; Puy Hervé; Deybach Jean-Charles; Minder Elisabeth I
Ancestral founder of mutation W283X in the porphobilinogen deaminase gene among acute intermittent porphyria patients.
Human heredity 2002;54(2):69-81.
-
2001: Pal T; Vogl F D; Chappuis P O; Tsang R; Brierley J; Renard H; Sanders K; Kantemiroff T; Bagha S; Goldgar D E; Narod S A; Foulkes W D
Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study.
The Journal of clinical endocrinology and metabolism 2001;86(11):5307-12.
-
2001: McKay J D; Lesueur F; Jonard L; Pastore A; Williamson J; Hoffman L; Burgess J; Duffield A; Papotti M; Stark M; Sobol H; Maes B; Murat A; Kääriäinen H; Bertholon-Grégoire M; Zini M; Rossing M A; Toubert M E; Bonichon F; Cavarec M; Bernard A M; Boneu A; Leprat F; Haas O; Lasset C; Schlumberger M; Canzian F; Goldgar D E; Romeo G
Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21.
American journal of human genetics 2001;69(2):440-6.
-
2000: Badzioch M; Eeles R; Leblanc G; Foulkes W D; Giles G; Edwards S; Goldgar D; Hopper J L; Bishop D T; Møller P; Heimdal K; Easton D; Simard J
Suggestive evidence for a site specific prostate cancer gene on chromosome 1p36. The CRC/BPG UK Familial Prostate Cancer Study Coordinators and Collaborators. The EU Biomed Collaborators.
Journal of medical genetics 2000;37(12):947-9.
-
2000: Rahman N; Teare M D; Seal S; Renard H; Mangion J; Cour C; Thompson D; Shugart Y; Eccles D; Devilee P; Meijers H; Nathanson K L; Neuhausen S L; Weber B; Chang-Claude J; Easton D F; Goldgar D; Stratton M R
Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22.
Oncogene 2000;19(36):4170-3.
-
2000: Lakhani S R; Gusterson B A; Jacquemier J; Sloane J P; Anderson T J; van de Vijver M J; Venter D; Freeman A; Antoniou A; McGuffog L; Smyth E; Steel C M; Haites N; Scott R J; Goldgar D; Neuhausen S; Daly P A; Ormiston W; McManus R; Scherneck S; Ponder B A; Futreal P A; Peto J; Stoppa-Lyonnet D; Bignon Y J; Stratton M R
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):782-9.
-
1999: Shugart Y Y; Cour C; Renard H; Lenoir G; Goldgar D; Teare D; Easton D; Rahman N; Gusterton R; Seal S; Barfoot R; Stratton M; Mangion J; Peelen T; van den Ouweland A; Meijers H; Devilee P; Eccles D; Lynch H; Weber B; Stoppa-Lyonnet D; Bignon Y J; Chang-Claude J
Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancer.
Journal of medical genetics 1999;36(9):720-1.
-
1999: Sinilnikova O M; Egan K M; Quinn J L; Boutrand L; Lenoir G M; Stoppa-Lyonnet D; Desjardins L; Levy C; Goldgar D; Gragoudas E S
Germline brca2 sequence variants in patients with ocular melanoma.
International journal of cancer. Journal international du cancer 1999;82(3):325-8.
-
1999: Lesueur F; Stark M; Tocco T; Ayadi H; Delisle M J; Goldgar D E; Schlumberger M; Romeo G; Canzian F
Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium.
The Journal of clinical endocrinology and metabolism 1999;84(6):2157-62.
-
1999: Puget N; Sinilnikova O M; Stoppa-Lyonnet D; Audoynaud C; Pagès S; Lynch H T; Goldgar D; Lenoir G M; Mazoyer S
An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation?
American journal of human genetics 1999;64(1):300-2.
-
1998: Neuhausen S L; Godwin A K; Gershoni-Baruch R; Schubert E; Garber J; Stoppa-Lyonnet D; Olah E; Csokay B; Serova O; Lalloo F; Osorio A; Stratton M; Offit K; Boyd J; Caligo M A; Scott R J; Schofield A; Teugels E; Schwab M; Cannon-Albright L; Bishop T; Easton D; Benitez J; King M C; Ponder B A; Weber B; Devilee P; Borg A; Narod S A; Goldgar D
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.
American journal of human genetics 1998;62(6):1381-8.
-
1998: Ford D; Easton D F; Stratton M; Narod S; Goldgar D; Devilee P; Bishop D T; Weber B; Lenoir G; Chang-Claude J; Sobol H; Teare M D; Struewing J; Arason A; Scherneck S; Peto J; Rebbeck T R; Tonin P; Neuhausen S; Barkardottir R; Eyfjord J; Lynch H; Ponder B A; Gayther S A; Zelada-Hedman M
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
American journal of human genetics 1998;62(3):676-89.
-
1998: Schuffenecker I; Virally-Monod M; Brohet R; Goldgar D; Conte-Devolx B; Leclerc L; Chabre O; Boneu A; Caron J; Houdent C; Modigliani E; Rohmer V; Schlumberger M; Eng C; Guillausseau P J; Lenoir G M
Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine.
The Journal of clinical endocrinology and metabolism 1998;83(2):487-91.
-
1997: Bignell G R; Canzian F; Shayeghi M; Stark M; Shugart Y Y; Biggs P; Mangion J; Hamoudi R; Rosenblatt J; Buu P; Sun S; Stoffer S S; Goldgar D E; Romeo G; Houlston R S; Narod S A; Stratton M R; Foulkes W D
Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer.
American journal of human genetics 1997;61(5):1123-30.
-
1997: Easton D F; Steele L; Fields P; Ormiston W; Averill D; Daly P A; McManus R; Neuhausen S L; Ford D; Wooster R; Cannon-Albright L A; Stratton M R; Goldgar D E
Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.
American journal of human genetics 1997;61(1):120-8.
-
1997: Goldgar D E; Easton D F
Optimal strategies for mapping complex diseases in the presence of multiple loci.
American journal of human genetics 1997;60(5):1222-32.
-
1997: Serova O M; Mazoyer S; Puget N; Dubois V; Tonin P; Shugart Y Y; Goldgar D; Narod S A; Lynch H T; Lenoir G M
Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?
American journal of human genetics 1997;60(3):486-95.
-
1997: Schuffenecker I; Ginet N; Goldgar D; Eng C; Chambe B; Boneu A; Houdent C; Pallo D; Schlumberger M; Thivolet C; Lenoir G M
Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine.
American journal of human genetics 1997;60(1):233-7.
-
1996: Mazoyer S; Dunning A M; Serova O; Dearden J; Puget N; Healey C S; Gayther S A; Mangion J; Stratton M R; Lynch H T; Goldgar D E; Ponder B A; Lenoir G M
A polymorphic stop codon in BRCA2.
Nature genetics 1996;14(3):253-4.
-
1996: Oddoux C; Struewing J P; Clayton C M; Neuhausen S; Brody L C; Kaback M; Haas B; Norton L; Borgen P; Jhanwar S; Goldgar D; Ostrer H; Offit K
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
Nature genetics 1996;14(2):188-90.
-
1996: Botkin J R; Croyle R T; Smith K R; Baty B J; Lerman C; Goldgar D E; Ward J M; Flick B J; Nash J E
A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing.
Journal of the National Cancer Institute 1996;88(13):872-82.
-
1996: Durocher F; Shattuck-Eidens D; McClure M; Labrie F; Skolnick M H; Goldgar D E; Simard J
Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations.
Human molecular genetics 1996;5(6):835-42.
-
1996: Offit K; Gilewski T; McGuire P; Schluger A; Hampel H; Brown K; Swensen J; Neuhausen S; Skolnick M; Norton L; Goldgar D
Germline BRCA1 185delAG mutations in Jewish women with breast cancer.
Lancet 1996;347(9016):1643-5.
-
1996: Neuhausen S; Gilewski T; Norton L; Tran T; McGuire P; Swensen J; Hampel H; Borgen P; Brown K; Skolnick M; Shattuck-Eidens D; Jhanwar S; Goldgar D; Offit K
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
Nature genetics 1996;13(1):126-8.
-
1996: Tavtigian S V; Simard J; Rommens J; Couch F; Shattuck-Eidens D; Neuhausen S; Merajver S; Thorlacius S; Offit K; Stoppa-Lyonnet D; Belanger C; Bell R; Berry S; Bogden R; Chen Q; Davis T; Dumont M; Frye C; Hattier T; Jammulapati S; Janecki T; Jiang P; Kehrer R; Leblanc J F; Mitchell J T; McArthur-Morrison J; Nguyen K; Peng Y; Samson C; Schroeder M; Snyder S C; Steele L; Stringfellow M; Stroup C; Swedlund B; Swense J; Teng D; Thomas A; Tran T; Tranchant M; Weaver-Feldhaus J; Wong A K; Shizuya H; Eyfjord J E; Cannon-Albright L; Tranchant M; Labrie F; Skolnick M H; Weber B; Kamb A; Goldgar D E
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.
Nature genetics 1996;12(3):333-7.
-
1996: Neuhausen S L; Mazoyer S; Friedman L; Stratton M; Offit K; Caligo A; Tomlinson G; Cannon-Albright L; Bishop T; Kelsell D; Solomon E; Weber B; Couch F; Struewing J; Tonin P; Durocher F; Narod S; Skolnick M H; Lenoir G; Serova O; Ponder B; Stoppa-Lyonnet D; Easton D; King M C; Goldgar D E
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.
American journal of human genetics 1996;58(2):271-80.
-
1995: Friend S; Borresen A L; Brody L; Casey G; Devilee P; Gayther S; Goldgar D; Murphy P; Weber B L; Wiseman R
Breast cancer information on the web.
Nature genetics 1995;11(3):238-9.
-
1995: Narod S; Ford D; Devilee P; Barkardottir R B; Eyfjord J; Lenoir G; Serova O; Easton D; Goldgar D
Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium.
American journal of human genetics 1995;57(4):957-8.
-
1995: Meyer L J; Schmidt L A; Goldgar D E; Piepkorn M W
Survival and histopathologic characteristics of human melanocytic nevi transplanted to athymic (nude) mice.
The American Journal of dermatopathology 1995;17(4):368-73.
-
1995: Goldgar D E
Analysis of familial breast cancer in genetic analysis workshop 9: summary of findings.
Genetic epidemiology 1995;12(6):833-6.
-
1995: Lewis C M; Goldgar D E
Screening for linkage using a multipoint identity-by-descent method.
Genetic epidemiology 1995;12(6):777-82.
-
1995: Goldgar D E; Neuhausen S L; Steele L; Fields P; Ward J H; Tran T; Ngyuen K; Stratton M R; Easton D F
A 45-year follow-up of kindred 107 and the search for BRCA2.
Journal of the National Cancer Institute. Monographs 1995;(17):15-9.
-
1994: Cannon-Albright L A; Meyer L J; Goldgar D E; Lewis C M; McWhorter W P; Jost M; Harrison D; Anderson D E; Zone J J; Skolnick M H
Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM).
Cancer research 1994;54(23):6041-4.
-
1994: Goldgar D E; Easton D F; Cannon-Albright L A; Skolnick M H
Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.
Journal of the National Cancer Institute 1994;86(21):1600-8.
-
1994: Cannon-Albright L A; Goldgar D E; Neuhausen S; Gruis N A; Anderson D E; Lewis C M; Jost M; Tran T D; Nyguen K; Kamb A
Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171.
Genomics 1994;23(1):265-8.
-
1994: Piepkorn M W; Barnhill R L; Cannon-Albright L A; Elder D E; Goldgar D E; Lewis C M; Maize J C; Meyer L J; Rabkin M S; Sagebiel R W
A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi.
Journal of the American Academy of Dermatology 1994;30(5 Pt 1):707-14.
-
1994: Cannon-Albright L A; Thomas A; Goldgar D E; Gholami K; Rowe K; Jacobsen M; McWhorter W P; Skolnick M H
Familiality of cancer in Utah.
Cancer research 1994;54(9):2378-85.
-
1994: Ford D; Easton D F; Bishop D T; Narod S A; Goldgar D E
Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Lancet 1994;343(8899):692-5.
-
1994: Goldgar D E; Fields P; Lewis C M; Tran T D; Cannon-Albright L A; Ward J H; Swensen J; Skolnick M H
A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis.
Journal of the National Cancer Institute 1994;86(3):200-9.
-
1993: Goldgar D E; Cannon-Albright L A; Oliphant A; Ward J H; Linker G; Swensen J; Tran T D; Fields P; Uharriet P; Skolnick M H
Chromosome 17q linkage studies of 18 Utah breast cancer kindreds.
American journal of human genetics 1993;52(4):743-8.
-
1993: Goldgar D E; Lewis C M; Gholami K
Analysis of discrete phenotypes using a multipoint identity-by-descent method: application to Alzheimer's disease.
Genetic epidemiology 1993;10(6):383-8.
-
1992: Cannon-Albright L A; Goldgar D E; Meyer L J; Lewis C M; Anderson D E; Fountain J W; Hegi M E; Wiseman R W; Petty E M; Bale A E
Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22.
Science (New York, N.Y.) 1992;258(5085):1148-52.
-
1992: Goldgar D E; Oniki R S
Comparison of a multipoint identity-by-descent method with parametric multipoint linkage analysis for mapping quantitative traits.
American journal of human genetics 1992;50(3):598-606.
-
1992: Goldgar D E; Cannon-Albright L A; Meyer L J; Piepkorn M W; Zone J J; Skolnick M H
Inheritance of nevus number and size in melanoma/DNS kindreds.
Cytogenetics and cell genetics 1992;59(2-3):200-2.
-
1992: Meyer L J; Goldgar D E; Cannon-Albright L A; Piepkorn M W; Zone J J; Risman M B; Skolnick M H
Number, size, and histopathology of nevi in Utah kindreds.
Cytogenetics and cell genetics 1992;59(2-3):167-9.
-
1991: Goldgar D E; Cannon-Albright L A; Meyer L J; Piepkorn M W; Zone J J; Skolnick M H
Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds.
Journal of the National Cancer Institute 1991;83(23):1726-33.
-
1991: Barker D F; Fain P R; Goldgar D E; Dietz-Band J N; Turco A E; Kashtan C E; Gregory M C; Tryggvason K; Skolnick M H; Atkin C L
High-density genetic and physical mapping of DNA markers near the X-linked Alport syndrome locus: definition and use of flanking polymorphic markers.
Human genetics 1991;88(2):189-94.
-
1991: Oliphant A R; Wright E C; Swensen J; Gruis N A; Goldgar D; Skolnick M H
Dinucleotide repeat polymorphism at the D17S514 locus.
Nucleic acids research 1991;19(17):4794.
-
1991: Oliphant A R; Wright E C; Swensen J; Gruis N A; Goldgar D; Skolnick M H
Dinucleotide repeat polymorphism at the D17S513 locus.
Nucleic acids research 1991;19(17):4794.
-
1991: Ahmed I; Piepkorn M; Goldgar D E; Cannon-Albright L A; Meyer L J; Skolnick M H; Zone J J
HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups.
Journal of cutaneous pathology 1991;18(4):257-60.
-
1990: Skolnick M H; Cannon-Albright L A; Goldgar D E; Ward J H; Marshall C J; Schumann G B; Hogle H; McWhorter W P; Wright E C; Tran T D
Inheritance of proliferative breast disease in breast cancer kindreds.
Science (New York, N.Y.) 1990;250(4988):1715-20.
-
1990: Goldgar D E
Multipoint analysis of human quantitative genetic variation.
American journal of human genetics 1990;47(6):957-67.
-
1990: Ahmed I; Piepkorn M W; Rabkin M S; Meyer L J; Feldkamp M; Goldgar D E; Skolnick M H; Zone J J
Histopathologic characteristics of dysplastic nevi. Limited association of conventional histologic criteria with melanoma risk group.
Journal of the American Academy of Dermatology 1990;22(5 Pt 1):727-33.
-
1990: Cannon-Albright L A; Goldgar D E; Wright E C; Turco A; Jost M; Meyer L J; Piepkorn M; Zone J J; Skolnick M H
Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome Ip36.
American journal of human genetics 1990;46(5):912-8.
-
1990: Wright E C; Goldgar D E; Fain P R; Barker D F; Skolnick M H
A genetic map of human chromosome 17p.
Genomics 1990;7(1):103-9.
-
1989: Fain P R; Goldgar D E; Wallace M R; Collins F S; Wright E; Nguyen K; Barker D F
Refined physical and genetic mapping of the NF1 region on chromosome 17.
American journal of human genetics 1989;45(5):721-8.
-
1989: Edwards C Q; Griffen L M; Goldgar D E; Skolnick M H; Kushner J P
HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda.
Gastroenterology 1989;97(4):972-81.
-
1989: Goldgar D E; Fain P R; Kimberling W J
Chiasma-based models of multilocus recombination: increased power for exclusion mapping and gene ordering.
Genomics 1989;5(2):283-90.
-
1989: Piepkorn M; Meyer L J; Goldgar D; Seuchter S A; Cannon-Albright L A; Skolnick M H; Zone J J
The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype.
Journal of the American Academy of Dermatology 1989;20(3):407-15.
-
1989: Goldgar D E; Green P; Parry D M; Mulvihill J J
Multipoint linkage analysis in neurofibromatosis type I: an international collaboration.
American journal of human genetics 1989;44(1):6-12.
-
1989: Goldgar D E; Fain P R; Green P
Multipoint analysis of 47 loci on chromosome 7q.
Progress in clinical and biological research 1989;329():23-8.
-
1988: Goldgar D E; Fain P R
Models of multilocus recombination: nonrandomness in chiasma number and crossover positions.
American journal of human genetics 1988;43(1):38-45.
-
1988: Edwards C Q; Griffen L M; Goldgar D; Drummond C; Skolnick M H; Kushner J P
Prevalence of hemochromatosis among 11,065 presumably healthy blood donors.
The New England journal of medicine 1988;318(21):1355-62.
-
1988: Elbein S C; Corsetti L; Goldgar D; Skolnick M; Permutt M A
Insulin gene in familial NIDDM. Lack of linkage in Utah Mormon pedigrees.
Diabetes 1988;37(5):569-76.
-
1987: Fain P R; Barker D F; Goldgar D E; Wright E; Nguyen K; Carey J; Johnson J; Kivlin J; Willard H; Mathew C
Genetic analysis of NF1: identification of close flanking markers on chromosome 17.
Genomics 1987;1(4):340-5.
-
1987: White R; Nakamura Y; O'Connell P; Leppert M; Lalouel J M; Barker D; Goldgar D; Skolnick M; Carey J; Wallis C E
Tightly linked markers for the neurofibromatosis type 1 gene.
Genomics 1987;1(4):364-7.
-
1987: Barker D; Wright E; Nguyen K; Cannon L; Fain P; Goldgar D; Bishop D T; Carey J; Kivlin J; Willard H
A genomic search for linkage of neurofibromatosis to RFLPs.
Journal of medical genetics 1987;24(9):536-8.
-
1987: Barker D; Wright E; Nguyen K; Cannon L; Fain P; Goldgar D; Bishop D T; Carey J; Baty B; Kivlin J
Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.
Science (New York, N.Y.) 1987;236(4805):1100-2.
Sign-in to see more
